Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc filed a Form 6-K for July 2022, dated July 22, 2022. The filing contains a corporate announcement rather than quarterly or annual financial results. Haleon is a global consumer-health company operating across 170 markets with more than 22,000 employees and product categories including oral health, pain relief, respiratory health, digestive health, vitamins, minerals and supplements.
Key financial metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, earnings-per-share or other financial performance metrics.
Material changes versus the prior comparable period
The filing text does not identify financial or operational changes versus a prior comparable period.
Corporate action, outlook and risks
Haleon announced the immediate appointment of Citigroup Global Markets Limited and UBS as its joint corporate brokers. No guidance, financial outlook, management forecast, material risk update, contingency, unusual item or transaction terms were disclosed.
Key facts for investors to verify
- Confirm the effective date and scope of the joint corporate broker appointments.
- Review subsequent company disclosures for financial results, guidance, capital structure and liquidity information.
- Assess any later announcements regarding Haleon’s listing, investor-relations arrangements or corporate governance.
- Note that this Form 6-K is an announcement filing and does not provide clear financial performance data.